Endocrinology

Back to articles

Guidance on long-term use of osteoporosis drugs

KEY POINT

Given the potential benefits and harms of long-term use of bisphosphonate therapy for the management of osteoporosis, the American Society for Bone and Mineral Research (ASBMR) released guidance on the appropriate duration of therapy for postmenopausal women, patients with glucocorticoid-induced osteoporosis, and men.